Skip to content

Agrify Corporation RYM Adjustments To Additional Paid In Capital Other

Adjustments To Additional Paid In Capital Other at other companies

Lightpath Technologies logo
Lightpath TechnologiesLPTH
$1.55M
Adient logo
AdientADNT
$7M+75.0%
CTO
Citius Oncology, Inc.CTOR
$9.25M
SVC
Stellar V Capital Corp. Class A Ordinary SharesSVCC
-$103.38K
Agrify Corporation logo
Agrify CorporationRYM
$942.75K
RE/MAX Holdings logo
RE/MAX HoldingsRMAX
-$35K-20.7%

Other financials

Income statement

See full
Revenue$13.3M+2,370%
Gross profit$10.4M+11,452%
Operating income-$4.0M-9.0%
Net income$19.9M+1,325%
EPS (diluted)$1.33+260%

Balance sheet

See full
Cash & equivalents$33.3M+36.0%
Total debt$89.2M+695%
Total equity$36.6M+36.4%
Total assets$127.5M+180%

Cash flow

See full
Operating cash flow$1.0M+116%
CapEx$2.0K+100%
Free cash flow-$1.8M+15.5%

Valuation

See full
Market cap$54.76M+33.0%
Enterprise value$110.74M+43.3%
P/S1.8×

Profitability

See full
Gross margin68.3%
Operating margin-108.8%
Net margin-39%
FCF margin-244.9%+1,014pp

Returns & leverage

See full
Return on equity-36.9%
Debt / equity2.4×+2.0×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by Agrify Corporation in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalOther.

The official record: Agrify Corporation’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agrify Corporation's adjustments to additional paid in capital other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agrify Corporation's adjustments to additional paid in capital other?
Agrify Corporation (RYM) reported adjustments to additional paid in capital other of $942.75K in Q4 2025.
What does adjustments to additional paid in capital other mean?
Represents miscellaneous adjustments to additional paid-in capital that do not fall under standard equity categories like stock-based compensation or debt conversions. This captures unique equity-related transactions that impact the company's capital structure. Investors monitor this to understand non-recurring equity adjustments that affect shareholder dilution and equity valuation.